171596-41-1

• 常用中文名：(1R,3r)-1,2,3,4-四氢-1-(3,4-亚甲基二氧基苯基)-9h-吡啶并[3,4-b]吲哚-3-羧酸甲酯
• 常用英文名：(1R,2S,3R)-(+)-3-[N-(BENZENESULFONYL)-N-(3,5-DIMETHYL-PHENYL)AMINO]-2-BORNANOL
• CAS号：171596-41-1
• 分子式：C₂₀H₁₈N₂O₄
• 分子量：350.36800
• 发布时间：2018-12-11 10:22:04
• 更新时间：2026-07-27 16:57:46

名称

• 中文名: (1R,3r)-1,2,3,4-四氢-1-(3,4-亚甲基二氧基苯基)-9h-吡啶并[3,4-b]吲哚-3-羧酸甲酯
• 英文名: (1r,3r)-methyl-1,2,3,4-tetrahydro-1-(3,4-methylenedioxyphenyl)-9h-pyrido[3,4-b]indole-3-carboxylate
• 中文别名: 他达那非盐酸盐(脱盐); 他达拉非杂质U; 他达那非杂质44; (1R,3R)-1-(苯并[D][1,3]二氧戊环-5-基)-2,3,4,9-四氢-1H-吡啶并[3,4-B]吲哚-3-羧酸甲酯; (1R,3R)-1,2,3,4-四氢-1-(3,4-亚甲基二氧基苯基)-9H-吡啶并[3,4-B]吲哚-3-羧酸甲酯; 他达那非中间体2非盐酸盐(脱盐); 顺式-(1R,3R)-1,2,3,4-四氢-1-(3,4-亚甲二氧基苯基)-9H-吡啶并[3,4-B]吲哚-3-羧酸甲酯; 他达非盐酸盐(脱盐); (1R,3R)-1,2,3,4-四氢-1-(3,4-亚甲二氧基苯基)-9H-吡啶并[3,4-B]吲哚-3-羧酸甲酯盐酸盐; (1R,3R)-1-(1,3-苯并二氧杂环戊烯-5-基)-2,3,4,9-四氢-1H-吡啶并[3,4-B]吲哚-3-羧酸甲酯; 顺式-(1R,3R)-1,2,3,4-四氢-1-(3,4-亚甲二氧基苯基)-9H-吡啶并[3,4-B]吲哚-3-羧酸甲酯他达那非中间体; 他达那非中间体2非盐酸盐; (1R,3R)-甲基 1-(苯并[D][1,3]二氧杂环戊烯-5-基)-2,3,4,9-四氢-1H-吡啶并[3,4-B]吲哚-3-甲酸酯; (1R,3R)-1-(1,3-苯并二氧杂环戊烯-5-基)-2,3,4,9-四氢-1H-吡啶并[3,4-b]吲哚-3-羧酸甲酯; 他达那非中间体(171-1); 他达那非中间体; (1R,3R)-1,2,3,4-四氢-1-(3,4-亚甲二氧基苯基)-9H-吡啶并[3,4-B]吲哚-3-羧酸甲酯
• 英文别名: 4-B]INDOLE-3-CBOXYLATE; (1R,3R)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester; (1R,3R)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-cboxylic Acid Methyl Ester; Tadalafil impurity 21/(1R,3R)-1-(3,4-methylenedioxyphenyl)-2,3,4,9-tetrahidro-9H-pyrido[3,4-b]indole-3-cboxylic acid methyl ester; Methyl (1R,3R)-1-(1,3-benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-cboxylateMethyl (1R,3R)-1-(1,3-benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-cboxylate; 1H-PYRIDO[3,4-B]INDOLE-3-CBOXYLICACID, 1-(1,3-BENZODIOXOL-5-YL)-2,3,4,9-TETRAHYDRO-METHYLESTER,(1R,3R); 3R)-METHYL-1; (1R,3R)-1-(3,4-Methylenedioxyphenyl); (1R,3R)-Methyl-1,2,3,4-tetrahydro-1-(3,4-Methylenedioxyphenyl)-9H-pyrido[3,4-b]indole-3-cboxylate HYDROCHLORIDE; (1R,3R)-methyl-1,2,3,4-tetrahydro-1-(3,4-methylenedioxypheny; (1R,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-cboxylate; EINECS 1312995-182-4; METHYL 1-(2H-1,3-BENZODIOXOL-5-YL)-1H,2H,3H,4H,9H-PYRIDO[3,4-B]INDOLE-3-CBOXYLATE; 4-METHYLENEDIOXYPHENYL)-9H-PYRIDO[3; methyl (1R,3R)-1-(2H-1,3-benzodioxol-5-yl)-1H,2H,3H,4H,9H-pyrido[3,4-b]indole-3-cboxylate; Tadalafil Impurity U; 4-TETRAHYDRO-1-(3; (1R,3R)-1-(3,4-methylenedioxyphenyl)-1,2,3,4-tetrahydro-pyrido[3,4-b]indole-3-carboxylic acid methyl ester; Methyl (1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-cboxylate; (1R,3R)-methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate; (1R,3R)-METHYL-1,2,3,4-TETRAHYDRO-1-(3,4-METHYLENEDIOXYPHENYL)-9H-PYRIDO[3,4-B]INDOLE-3-CBOXYLATE ISO 9001：2015 REACH; 1H-PYRIDO[3,4-B]INDOLE-3-CARBOXYLICACID,1-(1,3-BENZODIOXOL-5-YL)-2,3,4,9-TETRAHYDRO-METHYLESTER,(1R,3R); 1H-PYRIDO[3,4-B]INDOLE-3-CBOXYLIC ACID, 1-(1,3-BENZODIOXOL-5-YL)-2,3,4,9-TETRAHYDRO-, METHYL ESTER, (1R,3R); (1R,3R)-1-(3,4-methylenedioxyphenyl)-2,3,4,9-tetrahidro-9H-pyrido[3,4-b]indole-3-carboxylic acid methyl ester; Tadalafile Intermediate; (1R,3R)-METHYL-1,2,3,4-TETRAHYDRO-1-(3,4-METHYLENEDIOXYPHENYL)-9H-PYRIDO[3,4-B]INDOLE-3-CBOXYLATE; (1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-3-cboxylic acid methyl ester; Methyl (1R,3R)-1-(1,3-benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-cboxylate; (1R,3R)-1-(1,3-benzodioxol-5-yl)-2-(chloroacetyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b] indole-3-cbox; (1R,3R)-Methyl-1,2,3,4-tetrahydro-1-(3,4-Methylenedioxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxylate HYDROCHLORIDE; Tadalafil IntermediateⅢ

物化性质

• 密度: 1.359±0.06 g/cm3
• 沸点: 531.0±50.0 °C
• 熔点: 83-85°C
• 分子式: C₂₀H₁₈N₂O₄
• 分子量: 350.36800
• 精确质量: 350.12700
• PSA: 72.58000
• LogP: 3.00210

合成路线

上下游产品

上游产品  8
120-57-0 14907-27-8 4299-70-1 171596-42-2
67-56-1 1039484-71-3 749864-17-3 153-94-6
下游产品  4
171489-59-1 171596-27-3 171596-36-4 171596-29-5